Compare CSBR & RSSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CSBR | RSSS |
|---|---|---|
| Founded | 1985 | 2006 |
| Country | United States | United States |
| Employees | 214 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 68.8M | 71.2M |
| IPO Year | 2015 | 2008 |
| Metric | CSBR | RSSS |
|---|---|---|
| Price | $4.98 | $2.11 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $3.83 |
| AVG Volume (30 Days) | 12.5K | ★ 49.2K |
| Earning Date | 09-10-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 125.00 |
| EPS | N/A | ★ 0.09 |
| Revenue | $2,900,000.00 | ★ $28,793,922.00 |
| Revenue This Year | $9.83 | $1.40 |
| Revenue Next Year | $8.50 | $5.18 |
| P/E Ratio | ★ N/A | $24.11 |
| Revenue Growth | N/A | ★ 2.77 |
| 52 Week Low | $4.59 | $1.92 |
| 52 Week High | $8.31 | $3.78 |
| Indicator | CSBR | RSSS |
|---|---|---|
| Relative Strength Index (RSI) | 46.98 | 48.43 |
| Support Level | $4.71 | $2.00 |
| Resistance Level | $6.31 | $2.16 |
| Average True Range (ATR) | 0.26 | 0.07 |
| MACD | -0.00 | 0.01 |
| Stochastic Oscillator | 36.19 | 80.77 |
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment which is oncology services. Its research center operates in both regulatory and non-regulatory environments and consists of a comprehensive set of computational and experimental research platforms. The company's pharmacology, biomarker, and data platforms are designed to facilitate drug discovery and development at lower costs and increased speeds. Its revenue is majorly derived from research services.
Research Solutions Inc is a holding company. The company provides vertical software-as-a-service ("SaaS") and artificial intelligence ("AI") solutions, providing software and related services to help research-intensive organizations simplify the research process, save time, and money. The company operates in a single segment, which derives its revenue from subscription fees from the cloud-based SaaS Platforms and transactional service fees for the electronic delivery of single articles. The company generates the majority of its revenue from the Transactions. Geographically, the company generates the majority of its revenue from the United States, followed by Europe.